Abbott Laboratories : ABT

All Abbott Laboratories Articles

321 Articles

Jon C. Ogg | May 19, 2014 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Altria, CenturyLink, Micron, GoGo, AT&T and More

These are the top Wall Street analyst upgrades, downgrades and initiations seen on Monday, May 19, 2014. They include Altria,…

Paul Ausick | May 5, 2014 at 11:20 AM EDT

Why Target Shares Fell Rather Than Rose on CEO Firing

Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim…

Trey Thoelcke | Apr 29, 2014 at 9:25 AM EDT

Five Top Health Care Names From RBC to Buy Now

ThinkstockThe intense analysis of quantitative managers may seem like drudgery, but it can turn up absolute gems for investors looking…

Jon C. Ogg | Mar 27, 2014 at 9:15 AM EDT

Baxter Split-Up, a Page From Abbott’s Playbook

Baxter International is taking an activist investor role of its own. The health care company has announced that it is…

Jon C. Ogg | Jan 24, 2014 at 8:55 AM EST

Jefferies Highest Conviction Franchise Picks for Big Upside in 2014

The Jefferies "Franchise" stock picks for 2014 are an eclectic group that may offer investors some ideas that are not…

Jon C. Ogg | Jan 6, 2014 at 8:45 AM EST

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

These are the top analyst upgrades, initiations and positive analyst research calls seen from Wall Street on Monday, January 6.

Lee Jackson | Nov 20, 2013 at 8:30 AM EST

Top Oppenheimer Health Care Stocks to Buy for 2014

ThinkstockHealth care has been a top sector for investors this year. The research team at Oppenheimer continues to believe that…

Jon C. Ogg | Oct 2, 2013 at 12:25 PM EDT

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

ThinkstockWhen the markets go through periods of great gains, it is not uncommon to see companies start to take more…

Lee Jackson | Sep 25, 2013 at 9:00 AM EDT

Jefferies Top Stocks to Buy Based on Significant Margin Expansion

Courtesy of Abbott LaboratoriesWith many of the companies in the S&P 500 having margins approaching all-time highs, and implied S&P…

Trey Thoelcke | Jul 25, 2013 at 8:40 AM EDT

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

Frank Golhen, via Wikimedia CommonsWith the equity markets seemingly hitting new all-time highs every day, we were intrigued by the…

Douglas A. McIntyre | Jul 22, 2013 at 10:20 AM EDT

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

ThinkstockThe U.K.’s royal family is wealthy, but likely not wealthy enough to pass up sponsorships as the heir to the…

Paul Ausick | Jul 18, 2013 at 10:20 AM EDT

Exchange Rate Volatility Hampers Earnings: Who Gets Blamed?

ThinkstockFollowing last month’s Federal Open Market Committee (FOMC) meeting, the euro-U.S. dollar exchange rate (EURUSD) fell to just over 80. Less…

Paul Ausick | Jul 17, 2013 at 4:03 PM EDT

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Close with Small Gains

July 17, 2013: U.S. equity markets opened higher this morning and managed to hold onto a decent gain following a…

Paul Ausick | Jul 17, 2013 at 8:20 AM EDT

Abbott Labs Company Earnings Light on Revenues

ThinkstockAbbott Laboratories (NYSE: ABT) reported second-quarter 2013 results before markets opened this morning. The drugmaker reported adjusted diluted earnings per…

Paul Ausick | Jul 16, 2013 at 4:05 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Waiting for Bernanke Testimony

July 16, 2013: U.S. equity markets opened a bit higher this morning but almost instantly turned lower and remained in…

1 … 10 11 12 13 14 … 22

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top Analyst Upgrades and Downgrades: Altria, CenturyLink, Micron, GoGo, AT&T and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Five Top Health Care Names From RBC to Buy Now

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies Highest Conviction Franchise Picks for Big Upside in 2014

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Top Oppenheimer Health Care Stocks to Buy for 2014

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Jefferies Top Stocks to Buy Based on Significant Margin Expansion

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

Exchange Rate Volatility Hampers Earnings: Who Gets Blamed?

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Close with Small Gains

Abbott Labs Company Earnings Light on Revenues

Closing Bell for Tuesday on Wall Street: Markets Waiting for Bernanke Testimony

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Abbott Laboratories : ABT

All Abbott Laboratories Articles

Top Analyst Upgrades and Downgrades: Altria, CenturyLink, Micron, GoGo, AT&T and More

Why Target Shares Fell Rather Than Rose on CEO Firing

Five Top Health Care Names From RBC to Buy Now

Baxter Split-Up, a Page From Abbott’s Playbook

Jefferies Highest Conviction Franchise Picks for Big Upside in 2014

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Top Oppenheimer Health Care Stocks to Buy for 2014

Spin-Offs Back in Vogue: Six Must-Watch Special Situations

Jefferies Top Stocks to Buy Based on Significant Margin Expansion

UBS New Equity Focus List Features Stocks Designed to Outperform the Market

Royal Birth: Likely Corporate Sponsors Look At 240 Million Pound Windfall

Exchange Rate Volatility Hampers Earnings: Who Gets Blamed?

Closing Bell for Wednesday on Wall Street: Markets Open Higher, Close with Small Gains

Abbott Labs Company Earnings Light on Revenues

Closing Bell for Tuesday on Wall Street: Markets Waiting for Bernanke Testimony

Math Doesn’t Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

NVDL’s 2x Promise Delivered Only 17.21% While NVIDIA Soared 22.21% in One Year

Your 5% CD Is Gone and the Bank’s Renewal Offer Is Insulting. These 3 ETFs Keep Paying After the Fed Stops

Featured Reads

Math Doesn't Have Feelings: Dave Ramsey to a Debt-Free Caller Who Feels Like He Has Only $300 Left a Week on $105,000

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62